ContraFect Appoints Lisa Ricciardi as Chief Operating Officer
Oct 05, 2017 11:00 am UTC| Business
YONKERS, N.Y., Oct. 05, 2017 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious...
Sandy Spring Bancorp, Inc. to Webcast Third Quarter Earnings Conference Call on October 19, 2017
Oct 05, 2017 11:00 am UTC| Business
OLNEY, Md., Oct. 05, 2017 -- Sandy Spring Bancorp, Inc. (Nasdaq:SASR) will announce its third quarter earnings on Thursday, October 19, 2017. The company will hold a conference call that day at 2:00 p.m. (ET) to discuss...
Iridium Announces Release Date for Third-Quarter 2017 Financial Results
Oct 05, 2017 11:00 am UTC| Business
MCLEAN, Va., Oct. 05, 2017 -- Iridium Communications Inc. (Nasdaq:IRDM) (“Iridium”) will host a conference call on Thursday, October 26, 2017 at 8:30 a.m. Eastern Time (ET) to discuss the Company’s third-quarter 2017...
Air Lease Corporation Announces Third Quarter 2017 Earnings Conference Call
Oct 05, 2017 10:31 am UTC| Business
LOS ANGELES, Oct. 05, 2017 -- Air Lease Corporation (NYSE:AL) will host a conference call on November 9, 2017 at 4:30 PM Eastern Time to discuss the Company's financial results for the third quarter of 2017. Investors...
Oct 05, 2017 10:30 am UTC| Business
VANCOUVER, B.C., Oct. 05, 2017 -- Gold Standard Ventures Corp. (TSXV:GSV) (NYSE AMERICAN:GSV) (“Gold Standard” or the “Company”) today announced that results from 24 exploration holes have confirmed three high potential...
Oct 05, 2017 10:30 am UTC| Business
TORONTO, Oct. 05, 2017 -- NewCastle Gold Ltd. (TSX:NCA) (“NewCastle Gold” or the “Company”) is pleased to report the results of an independently supervised water pump testing program performed on the Company’s Castle...
CytoDyn Receives Orphan Drug Designation for PRO 140 for Prevention of Graft Versus Host Disease
Oct 05, 2017 10:00 am UTC| Business
VANCOUVER, Washington, Oct. 05, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that...